Patents by Inventor Paul H. Bonner

Paul H. Bonner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4547498
    Abstract: A novel combination pharmaceutical composition is described, together with a method for making the same, wherein the pharmaceutcially active ingredients are separately milled and then formed into separate granules, and only thereafter blended together to form the combination composition. The method for achieving this novel combination composition is also described. In particular, a novel combination composition of triamterene and hydrochlorothiazide having improved bioavialability and novel effectiveness to prevent or eliminate hypokalemic side effects is also described.
    Type: Grant
    Filed: February 17, 1984
    Date of Patent: October 15, 1985
    Assignee: Mylan Pharmaceuticals Inc.
    Inventors: Cheryl D. Blume, Paul H. Bonner
  • Patent number: 4526777
    Abstract: A novel combination pharmaceutical composition is described, together with a method for making the same, wherein the pharmaceutically active ingredients are separately milled and then formed into separate granules, and only thereafter blended together to form the combination composition. The method for achieving this novel combination composition is also described. In particular, a novel combination composition of triamterene and hydrochlorothiazide having improved bioavialability and novel effectiveness to prevent or eliminate hypokalemic side effects is also described.
    Type: Grant
    Filed: February 17, 1984
    Date of Patent: July 2, 1985
    Assignee: Mylan Pharmaceuticals Inc.
    Inventors: Cheryl D. Blume, Paul H. Bonner
  • Patent number: 4444769
    Abstract: A novel combination pharmaceutical composition is described, together with a method for making the same, wherein the pharmaceutically active ingredients are separately milled and then formed into separate granules, and only thereafter blended together to form the combination composition. The method for achieving this novel combination composition is also described. In particular, a novel combination composition of triamterene and hydrochlorothiazide having improved bioavailability and novel effectiveness to prevent or eliminate hypokalemic side effects is also described.
    Type: Grant
    Filed: January 6, 1983
    Date of Patent: April 24, 1984
    Assignee: Mylan Pharmaceuticals, Inc.
    Inventors: Cheryl D. Blume, Paul H. Bonner